Recurrent Melanoma Active Not Recruiting Phase 3 Trials for Interferon alfa-2b (DB00105)

Also known as: Melanoma Recurrent

IndicationStatusPhase
DBCOND0028662 (Recurrent Melanoma)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01274338Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by SurgeryTreatment